Colman Howard, Giannini Caterina, Huang Li, Gonzalez Javier, Hess Kenneth, Bruner Janet, Fuller Gregory, Langford Lauren, Pelloski Christopher, Aaron Joann, Burger Peter, Aldape Ken
Department of Neuro-Oncology, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Am J Surg Pathol. 2006 May;30(5):657-64. doi: 10.1097/01.pas.0000202048.28203.25.
Distinguishing between grade II and grade III diffuse astrocytomas is important both for prognosis and for treatment decision-making. However, current methods for distinguishing between grades based on proliferative potential are suboptimal, making identification of clear cutoffs difficult. In this study, we compared the results from immunohistochemical staining for phospho-histone H3 (pHH3), a specific marker of cells undergoing mitosis, with standard mitotic counts (number of mitoses/10 high-power fields) and MIB-1 labeling index values for assessing proliferative activity. We tested the relationship between pHH3 staining and tumor grade and prognosis in a retrospective series of grade II and III infiltrating astrocytomas from a single institution. The pHH3 index (per 1000 cells), MIB-1 index (per 1000 cells), and number of mitoses per 10 high-power fields were determined for each of 103 cases of grade II and III diffuse astrocytomas from patients with clinical follow-up. pHH3 staining was found to be a simple and reliable method for identifying mitotic figures, allowing a true mitotic index to be determined. The pHH3 mitotic index was significantly associated both with the standard mitotic count and with the MIB-1 index. Univariate analyses revealed that all 3 measurements of proliferation were significantly associated with survival. However, the pHH3 mitotic index accounted for a larger proportion of variability in survival than standard mitotic count or MIB-1/Ki-67 labeling index. After adjusting for age, extent of resection, and performance score, the pHH3 mitotic index remained an independent predictor of survival. Thus, pHH3 staining provides a simple and reliable method for quantifying proliferative potential and for the stratification of patients with diffuse astrocytomas into typical grade II and III groups. These results also suggest that pHH3 staining may be a useful method in other neoplasms in which accurate determination of proliferation potential is relevant to tumor grading or clinical treatment decision-making.
区分II级和III级弥漫性星形细胞瘤对于预后评估和治疗决策都很重要。然而,目前基于增殖潜能区分肿瘤级别的方法并不理想,难以确定明确的临界值。在本研究中,我们将有丝分裂特异性标志物磷酸化组蛋白H3(pHH3)免疫组化染色结果与标准有丝分裂计数(每10个高倍视野中的有丝分裂数)以及用于评估增殖活性的MIB-1标记指数值进行了比较。我们在一个机构的回顾性系列II级和III级浸润性星形细胞瘤中测试了pHH3染色与肿瘤级别及预后之间的关系。对103例有临床随访的II级和III级弥漫性星形细胞瘤患者的每例病例,分别测定其pHH3指数(每1000个细胞)、MIB-1指数(每1000个细胞)以及每10个高倍视野中的有丝分裂数。结果发现,pHH3染色是一种识别有丝分裂图像的简单可靠方法,能够确定真实的有丝分裂指数。pHH3有丝分裂指数与标准有丝分裂计数以及MIB-1指数均显著相关。单因素分析显示,所有这3种增殖测量指标均与生存显著相关。然而,pHH3有丝分裂指数在生存变异性中所占比例比标准有丝分裂计数或MIB-1/Ki-67标记指数更大。在调整年龄、切除范围和性能评分后,pHH3有丝分裂指数仍然是生存的独立预测指标。因此,pHH3染色为量化增殖潜能以及将弥漫性星形细胞瘤患者分层为典型的II级和III级组提供了一种简单可靠的方法。这些结果还表明,pHH3染色在其他肿瘤中可能也是一种有用的方法,在这些肿瘤中准确确定增殖潜能与肿瘤分级或临床治疗决策相关。